The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
To 'Post Your News' use the button at the top right.
We are pleased to present below all posts archived in 'July, 2017'. If you still can't find what you are looking for, try using the search box.
Horton International (UK), today launched its 2017 European Life Science Report, published following Horton’s annual survey amongst the movers and shakers within the European Life Science sector.
Read the rest of entry »
BioSeed®, a new conference created by OBN and Eurasanté, aims to showcase Europe’s most innovative early stage life sciences companies
26 July 2017, Abingdon, UK: OBN, the membership organisation supporting the UK’s innovative life sciences companies, is pleased to announce today that EY, global leader in assurance, tax, transaction and advisory services, has confirmed their support as Official Host of the first BioSeed® conference, taking place in London on 14 November 2017.
BioSeed® is the result of a shared vision between OBN and Eurasanté; with both parties aiming to fill the gap of industry events that solely support the interaction of early-stage companies with appropriate investors at a European level.
BioSeed® will run as a one-day event at EY's 1 More London Place office, on 14 November 2017 and will feature presentations and pitches by early-stage organisations and a series of pre-scheduled one-to-one meetings with potential investors.
For the full news article, please see http://www.bbc.co.uk/news/in-pictures-40582699
Hermes Investment Management (Hermes), the £30.8 billion manager, has agreed to sell a 50% equity stake in Milton Park to Canada Pension Plan Investment Board (CPPIB) for approximately £200 million.
Wickham Laboratories reports a successful completion of the MHRA audit process and the subsequent renewal of the GLP accreditation.
Isansys Lifecare Ltd is proud to announce it has been shortlisted for the Celebration of Innovation Awards 2017, a prestigious award celebrating the best of innovation in healthcare.
AMSBIO reports on an independent evaluation and use by I-Stem (Corbeil-Essonnes, France) of the Skeletal Muscle Differentiation kit - a cell culture media system to differentiate human stem cells into functional myotubes.
Oxford BioMedica (LSE:OXB) is a leading gene and cell therapy group focused on developing life changing treatments for serious diseases.
PCI Pharma Services (PCI) has affirmed its position relative to the delayed enforcement of the US Food and Drug Administration (FDA)’s Compliance Policy for ‘Product Identified Requirements Under the Drug Supply Chain Security Act' (DSCSA).
Ipsen has cut the price of its kidney cancer Cabometyx to help secure its place within the NHS’ routine commissioning stream, helping to over-turn a previous decision that it did not represent value for money.
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.